Amisulpride is an atypical antipsychotic associated with low weight gainLEUCHT, Stefan; WAGENPFEIL, Stefan; HAMANN, Johannes et al.Psychopharmacologia. 2004, Vol 173, Num 1-2, pp 112-115, issn 0033-3158, 4 p.Article

Amisulpride ― dose, plasma concentration, occupancy and response: implications for therapeutic drug monitoringSPARSHATT, A; TAYLOR, D; PATEL, M. X et al.Acta psychiatrica scandinavica. 2009, Vol 120, Num 6, pp 416-428, issn 0001-690X, 13 p.Article

Amisulpride: limbic specificity and the mechanism of antipsychotic atypicalityMÖLLER, Hans-Jürgen.Progress in neuro-psychopharmacology & biological psychiatry. 2003, Vol 27, Num 7, pp 1101-1111, issn 0278-5846, 11 p.Article

Amisulpride does not prevent relapse in primary alcohol dependence: Results of a pilot randomized, placebo-controlled trialMARRA, Donata; WAROT, Dominique; BERLIN, Ivan et al.Alcoholism, clinical and experimental research. 2002, Vol 26, Num 10, pp 1545-1552, issn 0145-6008, 8 p.Article

Les benzamides dans les schizophrénies déficitaires = Benzamide in deficiency schizophreniaMOUSSA BA; SYLLA, P.Comptes rendus de thérapeutique et de pharmacologie clinique. 1986, Vol 4, Num 40, pp 11-19, issn 0293-9908Article

Amisulpride poisoning. A case reportROUSSEL, Olivier; DUMILLARD, Céline; SADEG, Nouredine et al.Thérapie (Paris). 2006, Vol 61, Num 6, pp 534-536, issn 0040-5957, 3 p.Article

Therapeutic drug monitoring for optimizing amisulpride therapy in patients with SchizophreniaMÜLLER, Matthias J; REGENBOGEN, Boris; HÄRTTER, Sebastian et al.Journal of psychiatric research. 2007, Vol 41, Num 8, pp 673-679, issn 0022-3956, 7 p.Article

Amisulpride : Solian° : Solution buvable = Amisulpride: Solian: Drinkable solutionLa Revue Prescrire. 2001, Vol 21, Num 215, issn 0247-7750, p. 188Article

From research to clinical outcomes: progress with second-generation antipsychotics: proceedings of a symposium, Munich, September 9th, 2000Current medical research and opinion. Supplement. 2002, Vol 18, Num 3, issn 0141-9951, 28 p.Conference Proceedings

Psychiatrie = PsychiatryBERTSCHY, G; BRYOIS, C; FERRERO, F et al.Médecine et hygiène. 2000, Vol 58, Num 2284, pp 136-138, issn 0025-6749Article

Evaluation de l'efficacité et de la tolérance de l'amisulpride dans le traitement des psychoses schizophréniques = Treatment of psychosis with productive symptoms : efficacy and safety of amisulprideCHABANNES, J. P; PELISSOLO, A; FARAH, S et al.L' Encéphale (Paris). 1998, Vol 24, Num 4, pp 386-392, issn 0013-7006Article

Hyperprolactinemia induced by low-dosage amisulpride in Korean psychiatric patientsLEE, Bun-Hee; KANG, Seung-Gul; KIM, Tae-Woo et al.Psychiatry and clinical neurosciences (Carlton. Print). 2012, Vol 66, Num 1, pp 69-73, issn 1323-1316, 5 p.Article

The relative sensitivity of the clinical global impressions scale and the brief psychiatric rating scale in antipsychotic drug trialsLEUCHT, Stefan; ENGEL, Rolf R.Neuropsychopharmacology (New York, NY). 2006, Vol 31, Num 2, pp 406-412, issn 0893-133X, 7 p.Article

Early-onset hypothesis of antipsychotic drug action : A hypothesis tested, confirmed and extendedLEUCHT, Stefan; BUSCH, Raymonde; HAMANN, Johannes et al.Biological psychiatry (1969). 2005, Vol 57, Num 12, pp 1543-1549, issn 0006-3223, 7 p.Article

Dopaminergic deficit and the role of amisulpride in the treatment of schizophreniaKASPER, Siegfried.International clinical psychopharmacology. 2002, Vol 17, pp S19-S26, issn 0268-1315, SUP4Conference Paper

Spectroscopic investigation on the inclusion complex formation between amisulpride and γ-cyclodextrinJEETENDRA SINGH NEGI; SINGH, Shivpal.Carbohydrate polymers. 2013, Vol 92, Num 2, pp 1835-1843, issn 0144-8617, 9 p.Article

Two-year study of relapse prevention by a new education program in schizophrenic patients treated with the same antipsychotic drugCHABANNES, Jean-Paul; BAZIN, Nadine; LEGUAY, Denis et al.European psychiatry. 2008, Vol 23, Num 1, pp 8-13, issn 0924-9338, 6 p.Article

Antipsychotic combination using low-dose antipsychotics is as efficacious and safe as, but cheaper, than optimal-dose monotherapy in the treatment of schizophrenia: a randomized, double-blind studyLIN, Ching-Hua; WANG, Fu-Chiang; LIN, Shih-Chi et al.International clinical psychopharmacology. 2013, Vol 28, Num 5, pp 267-274, issn 0268-1315, 8 p.Article

Dopaminergic deficit and the role of amisulpride in the treatment of mood disordersMONTGOMERY, Stuart A.International clinical psychopharmacology. 2002, Vol 17, pp S9-S17, issn 0268-1315, SUP4Conference Paper

Amisulpride treatment of adolescent patients with schizophrenia or schizo-affective disordersVAROL TAS, Fatma; GUVENIR, Taner.European child & adolescent psychiatry. 2009, Vol 18, Num 8, pp 511-513, issn 1018-8827, 3 p.Article

Enantioselective analysis of amisulpride in pharmaceutical formulations by means of capillary electrophoresisMUSENGA, Alessandro; MANDRIOLI, Roberto; MORGANTI, Emanuele et al.Journal of pharmaceutical and biomedical analysis. 2008, Vol 46, Num 5, pp 966-970, issn 0731-7085, 5 p.Article

The antinociceptive effect of amisulpride in mice is mediated through opioid mechanismsWEIZMAN, Tal; PICK, Chaim G; BACKER, Maria M et al.European journal of pharmacology. 2003, Vol 478, Num 2-3, pp 155-159, issn 0014-2999, 5 p.Article

Is the superior efficacy of new generation antipsychotics an artifact of LOCF?LEUCHT, Stefan; ENGEL, Rolf R; BÄUML, Josef et al.Schizophrenia bulletin. 2007, Vol 33, Num 1, pp 183-191, issn 0586-7614, 9 p.Article

Pheochromocytoma unmasked by amisulpride and tiaprideHENRY, Agnès; CHARPIAT, Bruno; VIAL, Thierry et al.The Annals of pharmacotherapy. 2005, Vol 39, Num 5, pp 970-972, issn 1060-0280, 3 p.Article

Amisulpride: A review of its use in the management of schizophreniaMCKEAGE, Kate; PLOSKER, Greg L.CNS drugs. 2004, Vol 18, Num 13, pp 933-956, issn 1172-7047, 24 p.Article